Covington has advised Gilead Sciences, Inc. CMS and Goodwin Procter have advised Tubulis GmbH. Gilead Sciences, Inc. has entered into a definitive agreement to acquire Tubulis...
Gilead to Acquire Tubulis in $5 Billion Oncology-Focused Transaction
GoMetro’s £9 Million Series A Financing Round
Goodwin advised GoMetro on the financing. GoMetro, a South African tech company that operates in the fleet management space, has raised £9 million in a Series...
Moneyfarm’s Acquisition of Profile Pensions
Goodwin Procter advised Profile Pensions on the deal, while Linklaters advised Moneyfarm. Profile Pensions announced its proposed acquisition by Moneyfarm. Profile Pensions is a UK digital pension...
AbbVie’s Acquisition of DJS Antibodies
Goodwin Procter advised DJS Antibodies on the deal. AbbVie (NYSE: ABBV) announced the acquisition of DJS Antibodies Ltd (“DJS”), a privately-held UK-based biotechnology company dedicated to discovering...
Arcutis Biotherapeutics’ $400 Million Acquisition of Ducentis BioTherapeutics
Goodwin Procter advised Ducentis BioTherapeutics on the deal. Ducentis BioTherapeutics announced its acquisition by Arcutis Biotherapeutics for up to $400 million. Ducentis BioTherapeutics, a portfolio company of...
Pfizer’s $525 Million Acquisition of ReViral
Goodwin advised ReViral on the deal. Clifford Chance advised Pfizer. ReViral announced its acquisition by Pfizer. Pfizer will acquire ReViral for a total consideration of up to...
EyeBio’s $65 Million Series A Financing
Goodwin advised SV Health, Jeito and Samsara BioCapital on the deal. SV Health, Jeito and Samsara BioCapital led a $65 million Series A Financing of EyeBio. EyeBio...
Viatris’ $3.335 Billion Combination of Biosimilars Portfolio with Biocon Biologics
Cravath and Saraf and Partners represented Viatris in the transaction while Shardul Amarchand Mangaldas & Co and Goodwin Procter advised Biocon Biologics. Viatris Inc. reached a...
Leko Labs’ $21 Million Funding Round
Goodwin advised 2150 on the deal, while Chammas & Marcheteau represented the founders of LEKO LABS. Maples and Calder and Orrick UK acted for LEKO LABS....
Centauri Therapeutics’ $32 Million Series A Investment
Goodwin advised BIVF, Novo and Evotec on the deal. Boehringer Ingelheim Venture Fund GmbH (“BIVF”), Novo Holdings REPAIR Impact Fund (“Novo”) and Evotec SE (“Evotec”) led...
SFW Capital Partners’ Investment in Captify Technologies
Goodwin Procter advised Captify Technologies on the deal. Captify, the Search Intelligence Platform for the open web, announced that SFW Capital Partners, a leading US-based private...
bd-capital’s Investment in SportPursuit
Goodwin Procter LLP advised SportPursuit on the deal. bd-capital, the pan-European, operationally-led private equity firm, has made its latest investment today into SportPursuit, the leading online...